EUVIMEDDécouvrir EUVIMED
CrossrefCarte d’information

Duple-MONDNet: duple deep learning-based mobile net for motor neuron disease identification

SONY HELEN, JOSEPH JAWHAR

Turkish Journal of Medical Sciences · 2025-02-18 · 55 (1) · 140-151

DOI: 10.55730/1300-0144.5952 ↗
RésuméRéférences bibliographiques

Résumé

Background/aim: Motor neuron disease (MND) is a devastating neuron ailment that affects the motor neurons that regulate muscular voluntary actions. It is a rare disorder that gradually destroys aspects of neurological function. In general, MND arises as a result of a combination of natural, behavioral, and genetic influences. However, early detection of MND is a challenging task and manual identification is time-consuming. To overcome this, a novel deep learning-based duple feature extraction framework is proposed for the early detection of MND.Materials and methods: Diffusion tensor imaging tractography (DTI) images were initially analyzed for color and textural features using dual feature extraction. Local binary pattern (LBP)-based methods were used to extract textural data from images by examining nearby pixel values. A color information feature was then added to the LBP-based feature during the classification phase for extracting color features. A flattened image was then fed into the MONDNet for classifying normal and abnormal cases of MND based on color and texture features.Results: The proposed deep MONDNet is suitable because it achieved a detection rate of 99.66% and can identify MND in its early stages.Conclusion: The proposed mobile net model achieved an overall F1 score of 13.26%, 6.15%, 5.56%, and 5.96% compared to the BPNN, CNN, SVM-RFE, and MLP algorithms, respectively.

Des connaissances adaptées à votre travail.

D’un démarrage gratuit à la Research Suite complète, en passant par la recherche bibliographique personnelle.

Voir les tarifs →

Tous les textes intégraux sont-ils inclus ?

Non. Notices, résumés et textes intégraux sont des contenus distincts. La disponibilité dépend de la source, de l’accès ouvert et de vos licences. Une offre EUVIMED ne remplace pas des droits supplémentaires auprès des éditeurs.

Voir les tarifs →